Preeclampsia is the leading cause of maternal and fetal morbidity and mortality internationally, affecting approximately 2% to 5% of pregnancies.1 This pregnancy-specific syndrome generally develops after the 20th week of gestation, and is characterized by hypertension, edema, and pro-teinuria. Hemolysis, thrombocytopenia, and seizures may occur in more serious cases, and stroke, kidney, and multi-organ failure can lead to major maternal morbidity or death in the most severe cases. At the same time, reduced placen-tal blood flow can lead to fetal growth restriction, prematurity, and fetal morbidity and mortality.
展开▼
